Prediction: Lilly Will Reach $1,200 in 2026 — Investment Thesis
Eli Lilly’s GLP-1 drugs are redefining growth in obesity and diabetes treatment. This article lays out why the stock ...
Cashing in credit card points at the right time can yield maximum value. Learn the best strategies for optimizing your rewards.
25,491 articlesEli Lilly’s GLP-1 drugs are redefining growth in obesity and diabetes treatment. This article lays out why the stock ...
As SpaceX prepares to debut on the public market, analysts clash over whether the company is fairly valued amid volat...
Snowflake’s Q4 FY26 results hinge on one key metric—RPO—to gauge AI-driven demand and the strength of its data platfo...
As SpaceX moves closer to a historic IPO, investors are eyeing space peers for immediate upside. This report highligh...
A top investor argues the vast US financial economy is due for a shift into the physical economy, centered on metals ...
A landmark IPO move on July 7 could rewrite how investors think about liquidity and index dynamics. This guide breaks...
Thursday brought a lift to D-Wave stock as a quarterly momentum signal emerged. This guide breaks down the catalysts ...
AI is reshaping the data center landscape, and Marvell is at the center of the action. This piece breaks down why mar...
Broadcom posted a robust Q2 with AI-driven revenue rising sharply, but the stock pulled back. A bold market thesis, h...
NVIDIA and Palantir are teaming up to push AI into the most secure government environments. This article breaks down ...
A timely macro rebuttal from Citadel Securities challenges a viral AI-doomsday scenario, arguing that current data sh...
Warby Parker lit up the market with a notable stock move this week. This article breaks down the drivers behind the s...